West Pharmaceutical Services (WST)
(Delayed Data from NYSE)
$372.04 USD
-5.29 (-1.40%)
Updated Apr 19, 2024 04:00 PM ET
After-Market: $372.08 +0.04 (0.01%) 4:22 PM ET
3-Hold of 5 3
D Value B Growth D Momentum C VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
WST 372.04 -5.29(-1.40%)
Will WST be a Portfolio Killer in April?
Zacks Investment Research is releasing its prediction for WST based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for WST
West Pharmaceutical Services (WST) Expected to Beat Earnings Estimates: Should You Buy?
Reasons to Hold West Pharmaceutical (WST) in Your Portfolio Now
WST: What are Zacks experts saying now?
Zacks Private Portfolio Services
Merit Medical (MMSI) Down 0.6% Since Last Earnings Report: Can It Rebound?
Why Is Henry Schein (HSIC) Down 1.8% Since Last Earnings Report?
Reasons to Hold West Pharmaceutical (WST) in Your Portfolio Now
Other News for WST
Noteworthy Friday Option Activity: WST, ATGE, VKTX
Strong Buy: West Pharmaceutical Services’ Market Position and Growth Prospects in Drug Packaging Industry
West to Host First-Quarter 2024 Conference Call
West Pharmaceutical Services Inc. stock underperforms Tuesday when compared to competitors
(WST) - Analyzing West Pharmaceutical Servs's Short Interest